Oncology & Hematology Coding Alert
What Are Interferons? Review These Specifics
Interferons are biological response modifiers (“BRMs”).
Remember, these are not chemotherapeutic agents. According to the National Cancer Institute, “These substances may occur naturally in the body or may be made in the laboratory. Some biological response modifier therapies stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases. Other biological response modifier therapies attack specific cancer cells, which may help keep them from growing or kill them. They may also lessen certain side effects caused by some cancer treatments. Types of biological response modifier therapy include immunotherapy (such as vaccines, cytokines, and some antibodies), gene therapy, and some targeted therapies. Also called biological therapy, biotherapy, and BRM therapy.”
Interferons are used to treat patients with relapsing forms of multiple sclerosis and a number of hematological cancers like leukemias and lymphomas.
Oncology & Hematology Coding Alert
- HCPCS 2014:
Add These New Chemotherapy and Other Common Treatment Options
Look for new codes for both hematological and non-hematological chemotherapy. Effective Jan. 1, 2014, you’ll [...] - CPT® 2014:
Differentiate Trivalent and Quadrivalent Influenza Vaccines in 2014
Check for 90673 in the possible flu vaccine options. Each year, you face a challenge [...] - ICD-10-CM:
Laterality Is Key When Reporting Testicular Neoplasms
Anatomical location and side should be your focus in 2014. In ICD-10-CM, you can pick [...] - What Are Interferons? Review These Specifics
Interferons are biological response modifiers (“BRMs”). Remember, these are not chemotherapeutic agents. According to the [...] - You Be the Coder:
Do Not Miss Diagnosis Code for Metastatic Foci
Question: What ICD-9-CM code should we use to report prophylactic brain radiation in a patient [...] - Brush Up on Types of Testicular Neoplasms
Testicular cancers can have diverse histological types. More than 90 percent of all testicular cancers [...] - Reader Question:
Count Your Infusions
Question: Can you have more than one ‘first hour’ over an extended inpatient hospitalization? When [...] - Reader Question:
Confirm CT Data Sets Used in Treatment Planning
Question: In a patient who had secondaries in the brain, new bone secondaries are diagnosed. [...] - Reader Question:
Check Class for HLA Testing
Question: Our provider does testing for antibodies to HLA in a patient to confirm the [...]
